Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

    March 2021 in “ Cancers ”
    Tú Nguyen‐Dumont, James G. Dowty, Robert J. MacInnis … Melissa C. Southey
    Studysummary This study found that rare germline pathogenic variants in BRCA2, BRCA1, and ATM are associated with increased risk of aggressive prostate cancer.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study PubMed · 2002